Nonalcoholic Fatty Liver Disease research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE2
Phase 2b Study of GSK4532990 in Adults With NASH
This study is testing a new medicine, GSK4532990, for people with a serious liver condition called Non-Alcoholic Steatohepatitis (NASH). We want to see if this medicine can improve liver damage and inflammation compared to a dummy medicine.
United States · Argentina · Australia - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to compare two different aramchol formulations in healthy volunteers.
This study is testing two versions of a drug called aramchol in healthy people. It aims to see how safe they are and how the body handles them. This information helps scientists learn more about how to treat liver conditions like fatty liver disease.
Bulgaria - recruitingNA
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
This study looks at whether a daily pectin supplement, found in foods like citrus peel, can reduce inflammation and improve gut health in adults with a common liver condition called MASLD. Researchers want to see if it helps with overall health.
United Kingdom